Skip to content

A Randomized Controlled Trial of Theta Burst Transcranial Magnetic Stimulation for Post-Stroke Aphasia Naming Impairment

A Randomized Controlled Trial of Theta Burst Transcranial Magnetic Stimulation for Post-Stroke Aphasia Naming Impairment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122086
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-04-09
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Broca Stimulation Group:Conventional language training + active iTBS over left Broca’s area + sham iTBS over left DLPFC
DLPFC Stimulation Group:Conventional language training + sham iTBS over left Broca’s area + active iTBS over left DLPFC
Combined Stimulation Group:Conventional language training + active iTBS over left Broca’s area + active iTBS over left DLPFC

Sponsors

Guangdong Provincial Second Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for ischemic or hemorrhagic stroke, first onset, disease duration of 1–12 months; 2.Aged 18–70 years, regardless of gender; 3.Right-handed, with stroke lesions located in the left cerebral hemisphere; 4.Meet the diagnostic criteria for aphasia; 5.Normal language function prior to onset, native language not restricted, educational attainment of primary school or above (>=6 years of education); 6.Able to maintain a sitting position in a wheelchair for more than 40 minutes; 7.The patient and their family understand the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Aphasia caused by other diseases such as brain tumor, Parkinson’s syndrome, motor neuron disease, traumatic brain injury, etc.; 2.Complicated with severe cognitive impairment, dysarthria, or apraxia of speech; 3.Complicated with hearing impairment or visual impairment, unable to complete assessment and training; 4.Contraindications to transcranial magnetic stimulation, such as cardiac pacemaker, cochlear implant, intracranial metallic implants, etc.; 5.Skin damage or allergy on the head and face, or those who underwent decompressive craniectomy, ventriculoperitoneal shunt and other conditions unsuitable for near-infrared brain function detection; 6.History of epilepsy or high risk of epileptic seizures; 7.Severe depression, anxiety, or diagnosis of other mental disorders; 8.Pregnant women or women of childbearing age planning pregnancy.

Design outcomes

Primary

MeasureTime frame
Picture naming accuracy and mean reaction time;Western Aphasia Battery–Revised Chinese Version (WAB-R) AQ score;

Secondary

MeasureTime frame
Functional near-infrared spectroscopy (fNIRS);Trail Making Test (AMT-A);Working memory;

Countries

China

Contacts

Public ContactLi Jin

Guangdong Provincial Second Hospital of Traditional Chinese Medicine

melody7107@163.com+86 20 8348 2217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026